EPITHELIAL OVARIAN CANCER, FALLOPIAN TUBE OR PERITONEUM

Clinical trials for EPITHELIAL OVARIAN CANCER, FALLOPIAN TUBE OR PERITONEUM explained in plain language.

Never miss a new study

Get alerted when new EPITHELIAL OVARIAN CANCER, FALLOPIAN TUBE OR PERITONEUM trials appear

Sign up with your email to follow new studies for EPITHELIAL OVARIAN CANCER, FALLOPIAN TUBE OR PERITONEUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Engineered immune cells take on Hard-to-Treat ovarian cancer

Disease control Recruiting now

This study tests a new treatment called EB-DUALNK for adults with ovarian cancer that has come back or not responded to standard therapies. The treatment uses specially engineered natural killer (NK) cells designed to target two cancer-related markers at once. Participants first …

Matched conditions: EPITHELIAL OVARIAN CANCER, FALLOPIAN TUBE OR PERITONEUM

Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control

Last updated May 26, 2026 11:56 UTC

EPITHELIAL OVARIAN CANCER, FALLOPIAN TUBE OR PERITONEUM

Get alerted when new EPITHELIAL OVARIAN CANCER, FALLOPIAN TUBE OR PERITONEUM trials appear

Engineered immune cells take on Hard-to-Treat ovarian cancer